21st Sep 2015 16:42
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
21 September 2015
UDG Healthcare PLC
Publication of Circular and Notice of Extraordinary General Meeting
Further to the announcement on 18 September 2015, in which UDG Healthcare PLC ("UDG") announced that it had entered into a conditional agreement for the sale of certain assets, including United Drug Supply Chain Services businesses that form part of UDG's Supply Chain Services Division; and MASTA Business, which forms part of the Ashfield Commercial & Medical Services Division to McKesson, for an aggregate cash consideration of €407.5 million on a cash and debt free basis (the "Disposal"), UDG announces that the circular relating to the Disposal (the "Circular") has been approved by the UK Listing Authority and will be sent to shareholders shortly.
The Circular contains a notice of an extraordinary general meeting ("EGM") to approve the Disposal. The EGM will be held at 12 noon on 13 October 2015 at The Clyde Court Hotel, Lansdowne Road, Ballsbridge, Dublin 4, Ireland.
The Circular is available for inspection on the investor relations section of the Company's website: www.udghealthcare.com/investor-centre.
A copy of the Circular has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM
For further information, please contact:
Investors and Analysts: Alan Ralph CFO UDG Healthcare plc Tel: +353-1-463-2300
|
David Marshall Head of Investor Relations UDG Healthcare plc Tel: + 353-1-463-2518
|
Goldman Sachs International (Financial adviser and sponsor) Ben ThorpeChris Emmerson Tel: +44 (0) 20 7774 1000
| |
Jefferies (UK Corporate Broker) Simon Hardy Henry Elphick Tel: +44 (0) 20 7029 8000
| |
Media:
Business / Financial media:
Rory Godson / Lisa Kavanagh / Jack Hickey
Powerscourt
Tel: +44-207-250-1446
Trade Media (UK and Ireland):Mary Clark, Supriya Mathur, Hollie Vile
Hume BrophyTel: + 44 203 440 5657[email protected]
Important information
Goldman Sachs, which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively for UDG Healthcare plc and for no one else in relation to the Disposal and will not be responsible to anyone other than UDG Healthcare plc for providing the protections afforded to its clients or for providing advice in relation to the Disposal or any other matters referred to or described in this announcement.
Jefferies International Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for UDG Healthcare plc and for no one else in relation to the Disposal and will not be responsible to anyone other than UDG Healthcare plc for providing the protections afforded to its clients or for providing advice in relation to the Disposal or any other matters referred to or described in this announcement.
About UDG Healthcare plc:
Listed on the London Stock Exchange, UDG Healthcare plc is a leading international provider of services to healthcare manufacturers and pharmacies, with operations in 20 countries including the US, UK, Ireland and Germany.
UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services.
Ashfield Commercial & Medical Services is a global leader in the provision of sales, marketing and healthcare communications services to pharmaceutical manufacturers with operations in major developed markets. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to healthcare companies in 19 countries.
Sharp Packaging Services is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, the Netherlands and Belgium.
Supply Chain Services includes the United Drug Supply Chain Services and the Aquilant Specialist Healthcare Services businesses. The division provides logistics services to healthcare companies, pharmacies and hospitals in the UK and Ireland. United Drug Supply Chain Services is the largest pharmaceutical wholesaler and pre-wholesaler on the island of Ireland. Aquilant Specialist Healthcare Services is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in Ireland and the UK.
For more information please go to: www.udghealthcare.com
Related Shares:
UDG.L